ADVOS – ADVANCED ORGAN SUPPORT

The ADVOS procedure from ADVITOS is an innovative system for treating multiple organ failure in intensive care units: the world’s first dialysis treatment for acid-base homeostasis that comprises four organ support therapies.

A New Era in Extracorporeal Blood Purification

The new generation ADVOS BK300 offers a unique platform that enables fully integrated extracorporeal blood purification therapies with a treatment duration of up to 72 hours (RRT - renal replacement therapy)..

ADVOS BK300

More Chances of Survival for Intensive Care Patients

The ADVOS therapy simultaneously supports the kidneys, liver and lungs and additionally provides blood pH regulation in a single device. This can significantly increase the survival rate of patients in intensive care.

The ADVOS Therapy

ADVITOS – Innovative Medical Technology from Munich

The ADVOS therapy from ADVITOS is CE certified and patented worldwide. Our vision is to establish effective organ support and acidosis therapies as the standard of care for millions of intensive care patients worldwide.

ADVITOS - About Us

Current topics

The ADVOS multi
Targeted Multiple Organ Support

The Next Generation ADVOS BK300

A new era in extracorporeal blood purification

By playing, the YouTube provider may also set cookies and analyse your usage behaviour (tracking).
For more information, including a link to the provider's privacy policy, please see our privacy policy.

Load video

Always unlock YouTube